Male Urogenital Diseases

160 trials 69 recruiting

Filter these 160 trials by phase, country and sponsor.

Open in Search →

Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II … Ended

2024-513207-13-00 oligometastatic hormone sensitive prostate cancer 4 2019-03-21
TryptoBPH - Proof-of-concept study to evaluate the safety and efficacy of tryptophan in patients with BPH Halted

2024-519076-75-00 Benign prostatic hyperplasia 4 2024-12-05
A Study of Glucothera Plus for Peritoneal Dialysis in Children (ASTRA) Halted

2024-512078-88-00 End-stage Kidney Disease 5 2024-04-29
Safety and potential effect of innovative treatment by adjuvant injection of stromal vascular Fraction from autologous adipose tissue of URe… Halted

2024-513306-65-00 URethral stenosis 4 2024-03-13
Multicenter study on patient’s ability to independently and safely use of Sildenafil 100 mg for erectile dysfunction. Ended

2025-522923-81-00 Erectile dysfunction 6 2026-02-17
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517642-34-00 Benign prostatic hyperplasia (BPH) 2 2025-11-10
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study comparing Tamsulo… Ended

2024-517625-72-00 Benign prostatic hyperplasia (BPH) 2 2025-10-16
Neoadjuvant Lu-PSMA radioligand therapy and Ipilimumab in men with very high-risk prostate cancer (NEPI) Ended

2024-514386-19-00 Patients with very high-risk prostate cancer (as define 3 2025-08-25
NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia A clinical interventional trial Ended

2024-512996-11-00 Male infertility 4 2025-04-30
A Phase I, randomized, controlled, Latin-square, open-label study, to evaluate the effect of ADV7103 on gastric pH under fed and fasting con… Ended

2024-518764-13-00 distal renal tubular acidosis (dRTA) 3 2025-02-25
A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FU… Ended

2024-517967-22-00 healthy subjects 2 2025-02-25
A phase II trial to study the effectivity of combination immunotherapy in patients with prostate cancer (INSPIRE) Ended

2024-513186-39-01 castration-resistant prostate cancer 4 2025-02-01
DUET-study: A FEASIBILITY STUDY OF 177LU-PSMA RADIOLIGAND THERAPY ALTERNATED WITH RADIUM-223 IN PATIENTS WITH BONE-METASTATIC, OLIGO-METASTA… Ended

2024-518985-29-02 Prostate cancer 7 2024-11-21
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment Ended

2024-514359-14-00 Impaired renal function 3 2024-11-18
A Phase 2a, Randomised, Double-blind, Parallel and Placebo-controlled Trial Investigating Safety and Efficacy of LIB-01 in Treatment of Erec… Ended

2024-515065-34-00 Erectile dysfunction (ED) 4 2024-11-07
A phase 2b dose finding study of RMC-035 in participants undergoing open-chest cardiac surgery Ended

2024-510658-28-00 Loss of renal function following cardiac surgery 4 2024-09-24
EPI-7386 in Combination with Enzalutamide versus Enzalutamide alone in Metastatic Castration-Resistant Prostate Cancer Ended

2023-509336-25-00 Metastatic castration-resistant prostate cancer 9 2024-06-12
NAPO - Novel Approach for Oligospermia Ended

2023-508325-27-00 Male infertility 4 2024-04-01
A first human dose study to assess the safety, tolerability, pharmacokinetics and target engagement of single doses of NNC6022-0001 in healt… Ended

2023-505026-34-00 Cardiometabolic diseases 1 2024-03-26
A randomized, open-label, single dose, cross-over study to evaluate the drug-drug interaction between Proscar 5 mg, film-coated tablets and … Ended

2024-510774-24-00 healthy male subjects 3 2024-03-25
Ilofotase alfa for prevention of renal damage after cardiac surgery Ended

2023-505859-45-00 Risk for renal damage following open heart surgery 4 2023-12-19
Pharmacokinetics study of Cefazolin in haemodialysis Ended

2023-506734-73-00 Chronic haemodialysis patients suffering from infection 6 2023-11-20
Study evaluating PSMA targeted radionuclide therapy in adult patients with metastatic clear cell renal cancer Ended

2022-502440-12-00 metastatic clear cell renal cancer with progressive dis 9 2023-11-16
A study to see how well PLS240 works in treating secondary hyperparathyroidism, and how safe it is, in end stage kidney disease participants… Ended

2023-504338-24-00 ESKD participants with history of secondary hyperparath 5 2023-11-09